Analysis of the interaction of viral RNA replication proteins by using the yeast two-hybrid assay.

Por O'Reilly, E K, Paul, J D, Kao, C C
Publicado em 1997

Caffeine and alcohol intakes have no association with risk of multiple sclerosis in a prospective study of women

Por Massa, J., O’Reilly, E.J., Munger, K.L., Ascherio, A.
Publicado em 2012

Plasma urate and risk of Parkinson’s disease

Por Weisskopf, M. G., O’Reilly, E., Chen, H., Schwarzschild, M. A., Ascherio, A.
Publicado em 2007

Serum titers of IgG antibodies against tetanus and diphtheria toxoids and risk of multiple sclerosis

Por Massa, J., Munger, K.L., O'Reilly, E.J., Levin, L.I., Ascherio, A.
Publicado em 2009

Serum uric acid and risk of multiple sclerosis

Por Massa, J., O’Reilly, E., Munger, K.L., DeLorenze, G.N., Ascherio, A.
Publicado em 2009

Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel

Por Munger, K. L., Levin, L. I., O’Reilly, E. J., Falk, K. I., Ascherio, A.
Publicado em 2011

Running in the family: A rare diagnosis of familial papillary thyroid cancer

Por O’Connell, L., Prichard, R.S., O’Reilly, E., Skehan, S., Gibbons, D., McDermott, E.W.
Publicado no Int J Surg Case Rep (2015)

Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis

Por Simon, K. C., O'Reilly, E. J., Munger, K. L., Finerty, S., Morgan, A. J., Ascherio, A.
Publicado em 2012

Persistent organochlorine pesticides in serum and risk of Parkinson disease

Por Weisskopf, M.G., Knekt, P., O'Reilly, E.J., Lyytinen, J., Reunanen, A., Laden, F., Altshul, L., Ascherio, A.
Publicado em 2010

Alcohol and Risk of Parkinson Disease in a Large Prospective Cohort of Men and Women

Por Palacios, N., Gao, X., O’Reilly, E., Schwarzschild, M., McCullough, M.L., Mayo, T., Gapstur, S.M., Ascherio, A.
Publicado em 2012

Temporal relationship between cigarette smoking and risk of Parkinson disease

Por Thacker, E.L., O’Reilly, E.J., Weisskopf, M.G., Chen, H., Schwarzschild, M.A., McCullough, M.L., Calle, E.E., Thun, M.J., Ascherio, A.
Publicado em 2007

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031

Por Picozzi, V. J., Abrams, R. A., Decker, P. A., Traverso, W., O'Reilly, E. M., Greeno, E., Martin, R. C., Wilfong, L. S., Rothenberg, M. L., Posner, M. C., Pisters, P. W. T.
Publicado em 2011

A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocar...

Por Li, D., Pant, S., Ryan, D.P., Laheru, D., Bahary, N., Dragovich, T., Hosein, P.J., Rolfe, L., Saif, M.W., LaValle, J., Yu, K.H., Lowery, M.A., Allen, A., O'Reilly, E.M.
Publicado no Pancreatology (2014)

The College of General Practitioners

Por Carney, Desmond, O'Dea, J. St. L., McCann, John J., O'Reilly, E. A., O'Byrne, Andrew E. H., Kearon, D. S., O'Meara, Robert, Masterson, Laurence, Fleetwood, John, O'Grady, J. F., McNally, Nora, Ryan, A.
Publicado em 1953

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas

Por Lee, J K, Capanu, M, O'Reilly, E M, Ma, J, Chou, J F, Shia, J, Katz, S S, Gansukh, B, Reidy-Lagunes, D, Segal, N H, Yu, K H, Chung, K-Y, Saltz, L B, Abou-Alfa, G K
Publicado em 2013

Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer(†)

Por Wolpin, B. M., O'Reilly, E. M., Ko, Y. J., Blaszkowsky, L. S., Rarick, M., Rocha-Lima, C. M., Ritch, P., Chan, E., Spratlin, J., Macarulla, T., McWhirter, E., Pezet, D., Lichinitser, M., Roman, L., Hartford, A., Morrison, K., Jackson, L., Vincent, M., Reyno, L., Hidalgo, M.
Publicado em 2013